Literature DB >> 23329897

The practical management of treatment failure in chronic hepatitis C: a summary of current research and management options for refractory patients.

Tarek Hassanein1, Mitchell L Shiffman, Nizar N Zein.   

Abstract

Entities:  

Year:  2007        PMID： 23329897      PMCID： PMC3099312     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  145 in total

Review 1.  Side effects of therapy of hepatitis C and their management.

Authors:  Michael W Fried
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

Review 2.  Impact of obesity on treatment of chronic hepatitis C.

Authors:  Michael R Charlton; Paul J Pockros; Stephen A Harrison
Journal:  Hepatology       Date:  2006-06       Impact factor: 17.425

3.  Treatment of chronic hepatitis C virus in African Americans with genotypes 2 and 3.

Authors:  Mitchell L Shiffman; Anastasios A Mihas; Farida Millwala; Richard K Sterling; Velimir A Luketic; R Todd Stravitz; Arun J Sanyal
Journal:  Am J Gastroenterol       Date:  2007-02-23       Impact factor: 10.864

4.  Relationship of health-related quality of life to treatment adherence and sustained response in chronic hepatitis C patients.

Authors:  David Bernstein; Leah Kleinman; Chris M Barker; Dennis A Revicki; Jesse Green
Journal:  Hepatology       Date:  2002-03       Impact factor: 17.425

5.  Adherence to combination therapy: influence on sustained virologic response and economic impact.

Authors:  Michael P Manns
Journal:  Gastroenterol Clin North Am       Date:  2004-03       Impact factor: 3.806

6.  Changes in haemoglobin during interferon alpha-2b plus ribavirin combination therapy for chronic hepatitis C virus infection.

Authors:  M S Sulkowski; R Wasserman; L Brooks; L Ball; R Gish
Journal:  J Viral Hepat       Date:  2004-05       Impact factor: 3.728

7.  Interferon-alpha-induced changes in tryptophan metabolism. relationship to depression and paroxetine treatment.

Authors:  Lucile Capuron; Gabriele Neurauter; Dominique L Musselman; David H Lawson; Charles B Nemeroff; Dietmar Fuchs; Andrew H Miller
Journal:  Biol Psychiatry       Date:  2003-11-01       Impact factor: 13.382

8.  A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. Multicenter Study Group.

Authors:  T Poynard; P Bedossa; M Chevallier; P Mathurin; C Lemonnier; C Trepo; P Couzigou; J L Payen; M Sajus; J M Costa
Journal:  N Engl J Med       Date:  1995-06-01       Impact factor: 91.245

9.  A prospective study of the incidence and open-label treatment of interferon-induced major depressive disorder in patients with hepatitis C.

Authors:  P Hauser; J Khosla; H Aurora; J Laurin; M A Kling; J Hill; M Gulati; A J Thornton; R L Schultz; A D Valentine; C A Meyers; C D Howell
Journal:  Mol Psychiatry       Date:  2002       Impact factor: 15.992

10.  Treatment of chronic HCV infection in special populations.

Authors:  John Hoefs; Vikramjit S Aulakh
Journal:  Int J Med Sci       Date:  2006-04-01       Impact factor: 3.738
View more
  2 in total

1.  Budget impact and cost-effectiveness analyses of direct-acting antivirals for chronic hepatitis C virus infection in Hong Kong.

Authors:  X Li; N S Chan; A W Tam; I F N Hung; E W Chan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-05-17       Impact factor: 3.267

2.  Comparison of liver biopsies before and after direct-acting antiviral therapy for hepatitis C and correlation with clinical outcome.

Authors:  Omar A Saldarriaga; Bradley Dye; Judy Pham; Timothy G Wanninger; Daniel Millian; Michael Kueht; Benjamin Freiberg; Netanya Utay; Heather L Stevenson
Journal:  Sci Rep       Date:  2021-07-15       Impact factor: 4.379
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.